DAN:TCM
$1.03
5.295%

Prelude Therapeutics Incorporated
Insider Activity

Last updated: Jun 9, 2025, 3:14 AM ET

Profile

Company Description

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.

Sector

Healthcare

Industry

Biotechnology